Etoricoxib selectively inhibited COX-2 in human whole blood assays in vitro, with an IC50 value of 1.1 0.1 M for COX-2 (LPS-induced prostaglandin E2 synthesis), compared with an IC50 value of 116 8 M for COX-1 (serum thromboxane B2 generation after clotting of the blood).
仅供研究使用。 我们不向患者出售。
化学信息
| 名称 | Etoricoxib |
| Iupac 化学名称 | 5-chloro-2-(6-methylpyridin-3-yl)-3-(4-methylsulfonylphenyl)pyridine |
| 同义词 | Arcoxia; MK-663; MK-0663 |
| 英文同义词 | Arcoxia; MK-663; MK-0663 |
| 分子式 | C18H15ClN2O2S |
| 分子量 | 358.84 |
| Smile | ClC=1C=C(C(=NC1)C=1C=NC(=CC1)C)C1=CC=C(C=C1)S(=O)(=O)C |
| InChiKey | MNJVRJDLRVPLFE-UHFFFAOYSA-N |
| InChi | InChI=1S/C18H15ClN2O2S/c1-12-3-4-14(10-20-12)18-17(9-15(19)11-21-18)13-5-7-16(8-6-13)24(2,22)23/h3-11H,1-2H3 |
| Cas号 | 202409-33-4 |
| 相关CAS号 | |
| 外观性状 | Solid powder |
| 纯度 | 98% |
| 存储 | -20 ºC for 3 years |
| 可溶性 | Soluble in DMSO |
| 处理方式 | |
| 运输条件 | Shipped under ambient temperature |
| 海关编码 | |
| Targets | |
| Mechanism | |
| Cell study | |
| Animal study | |
| Clinical study | |